Abstract

The prognostic role of D-dimer in different types of heart failure (HF) is poorly understood. We investigated the prognostic value of D-dimer on admission, both independently and in combination with the Get With The Guidelines—Heart Failure (GWTG-HF) risk score and N-terminal pro-B-type natriuretic peptide (NT-proBNP), in patients with preserved left ventricular ejection fraction (LVEF) and acute decompensated HF (HFpEF) or reduced LVEF (HFrEF). Baseline D-dimer levels were measured on admission in 1670 patients (mean age: 75 years) who were hospitalized for worsening HF. Of those patients, 586 (35%) were categorized as HFpEF (LVEF ≥ 50%) and 1084 as HFrEF (LVEF < 50%). During the 12-month follow-up period after admission, 360 patients died. Elevated levels (at least the highest tertile value) of D-dimer, GWTG-HF risk score, and NT-proBNP were all independently associated with mortality in all HFpEF and HFrEF patients (all p < 0.05). Adding D-dimer to a baseline model with a GWTG-HF risk score and NT-proBNP improved the net reclassification and integrated discrimination improvement for mortality greater than the baseline model alone in all populations (all p < 0.001). The number of elevations in D-dimer, GWTG-HF risk score, and NT-proBNP were independently associated with a higher risk of mortality in all study populations (HFpEF and HFrEF patients; all p < 0.001). The combination of D-dimer, which is independently predictive of mortality, with the GWTG-HF risk score and NT-proBNP could improve early prediction of 12-month mortality in patients with acute decompensated HF, regardless of the HF phenotype.

Highlights

  • D-dimer is the end product of plasmin-mediated degradation of cross-linked fibrin.Plasma concentrations of D-dimer, a marker of coagulation, are dependent on fibrin generation and subsequent degradation by the endogenous fibrinolytic system [1]

  • 586 (35%) patients were categorized as HF with preserved ejection fraction (HFpEF) and 1084 as HF with reduced ejection fraction (HFrEF)

  • Similar results dently associated with all-cause mortality when assessed as either continuous variables or were obtained when patients were divided into tertiles according to GWTG-heart failure (HF) risk score categorized into two groups the ≥43 thirdpoints) tertile value in all patients,(1st, a subcohort of

Read more

Summary

Introduction

D-dimer is the end product of plasmin-mediated degradation of cross-linked fibrin. Plasma concentrations of D-dimer, a marker of coagulation, are dependent on fibrin generation and subsequent degradation by the endogenous fibrinolytic system [1]. Several studies have suggested that elevated D-dimer levels are associated with adverse outcomes in patients hospitalized for HF [4,5,6,7]. The Get With The Guidelines—Heart Failure (GWTG-HF) risk score was established to predict in-hospital mortality in patients with acute HF [12]. Previous studies have shown improved predictions of adverse outcomes following the addition of natriuretic peptides to the GWTG-HF risk score in patients with acute HF [18,19,20,21]. We assessed the prognostic value of D-dimer levels both independently and in combination with the GWTG-HF risk score and NT-proBNP levels, for acute decompensated HF patients with HFpEF and HFrEF

Study Design
Definitions and Calculations
Outcomes
Measurement of Biochemical Markers
Statistical Analyses
Baseline Characteristics and Outcomes
Discrimination and Reclassification of D-Dimer for Mortality
Discussion
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call